Theresa A. Graves

Centre for the Observation and Modelling of Earthquakes, Volcanoes and Tectonics — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

14h-index1.3kcitations42works22.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(25), Breast Lesions and Carcinomas(14), Advanced Radiotherapy Techniques(8), HER2/EGFR in Cancer Research(8), Estrogen and related hormone effects(6)

Publications40 total

Is Axillary Lymph Node Dissection Needed? Clinicopathological Correlation in a Series of 224 Neoadjuvant Chemotherapy-Treated Node-Positive Breast Cancers
Clinical Breast Cancer·2024· 1 cited
Phase II Trial of Five-Fraction Accelerated Partial Breast Irradiation Using Noninvasive Image-Guided Breast Brachytherapy
International Journal of Radiation Oncology*Biology*Physics·2023
PP06  Presentation Time: 5:15 PM
Brachytherapy·2023
Microinvasive breast cancer and the role of sentinel lymph node biopsy
Scientific Reports·2022· 9 citedOpen Access
Microinvasive breast cancer and the role of sentinel lymph node biopsy
Research Square (Research Square)·2021Open Access
Neoadjuvant Weekly Paclitaxel and Carboplatin with Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: A Brown University Oncology Research Group (BrUOG) Study
Research Square (Research Square)·2021· 1 citedOpen Access
Phase 2 Trial of Accelerated Partial Breast Irradiation (APBI) Using Noninvasive Image Guided Breast Brachytherapy (NIBB)
International Journal of Radiation Oncology*Biology*Physics·2020· 10 cited
Abstract P2-16-19: Neoadjuvant weekly paclitaxel (wP) and carboplatin (Cb) with trastuzumab (T) and pertuzumab (P) in HER2-positive breast cancer (H+BC): A Brown University oncology group (BrUOG) study
Cancer Research·2020· 1 cited
Abstract P2-14-20: The impact of recurrence score versus sentinel lymph node biopsy on treatment decisions in early breast cancer
Cancer Research·2020
Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/HER2-positive breast cancer
BMC Cancer·2019· 7 citedOpen Access
Distress: Characterizing What Causes the Thermometer to Shift in Patients with Newly Diagnosed Breast Cancer Attending a Multidisciplinary Clinic
Annals of Surgical Oncology·2019· 12 cited
Additional file 1: of Stromal ColXÎą1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/HER2-positive breast cancer
Figshare·2019Open Access
Three-Dimensional Bioabsorbable Tissue Marker Placement is Associated with Decreased Tumor Bed Volume Among Patients Receiving Radiation Therapy for Breast Cancer
Practical Radiation Oncology·2018· 12 cited
Five fraction accelerated partial breast irradiation using noninvasive image-guided breast brachytherapy: Feasibility and acute toxicity
Brachytherapy·2018· 14 cited
Can Sentinel Lymph Node Biopsy Be Spared in Papillary Carcinoma of the Breast?
Clinical Breast Cancer·2016· 16 cited
Initial Experience of Five Fraction Accelerated Partial Breast Irradiation (APBI) Using Non-Invasive Image-Guided Breast Brachytherapy (NIBB)
Brachytherapy·2016Open Access
Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer
BMC Cancer·2016· 45 citedOpen Access
Additional file 5: Table S4. of Identification of stromal ColXÎą1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer
Figshare·2016Open Access
Additional file 1: Table S1. of Identification of stromal ColXÎą1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer
Figshare·2016Open Access
Additional file 4: Table S3. of Identification of stromal ColXÎą1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer
2016
page 1 of 2Next →

Frequent Co-authors

Mary Anne Fenton(12), Yihong Wang(11), David E. Wazer(9), William M. Sikov(9), K.L. Leonard(9), Doreen L. Wiggins(9), Alexander S. Brodsky(8), Dongfang Yang(8), Jaroslaw T. Hepel(8), William G. Cioffi(7), Sandra Sha(7), William F. McManus(6), Jinjun Xiong(6), Christoph Schorl(6), Murray Resnick(6), Thomas A. DiPetrillo(5), Basil A. Pruitt(5), Kirby I. Bland(5), Jennifer Gass(5), Arthur D. Mason(4)